I am honored to speak on MASLD/ MASH at the Japan Atherosclerosis Society's conference. I’m truly humbled to share the stage with two legends and giants in the field, Professor Atsushi Nakajima and APASL President Professor Lai Wei. Thank you for kind invitation. #GIPMK

Happy to see @l_suthat in Phuket

Honored to be invited to give a talk in Da Nang, Vietnam on MASLD and MetALD in Metabolic Council Conference 2025. It was a great opportunity to exchange knowledge and insights with leading experts in the field. Grateful for the warm welcome and meaningful discussions. #GIPMK

Thank you for having me in .“Advances in MASLD Therapy” session. Digestive Disease Week® (DDW®).@DDWMeeting .#DDW2025

Be gutsy at #DDW2025

Proud to share that our team will present 9 presentations at DDW 2025 this year! A big thank you to everyone in our team for their dedication and hard work. Looking forward to an inspiring and collaborative experience at #DDW2025. #GIPMK

Semaglutide in MASH: Phase 3 ESSENCE trial just dropped!.✅ 63% achieved MASH resolution (vs. 34% placebo) in 72 wks.✅36% had fibrosis improvement (vs. 22%) in 72 wks.✅Avg. weight loss: −10.5% (vs. −2%). Full text: #MASLD.#MASH.#ESSENCE

Join me in person or online at #DDW2025 to get the latest advancements in the digestive disease field. Register today to hear my presentation at .

Happy Songkran festival with the cherry blossoms 🌸

We would like to thank Professor Amit G. Singal from the University of Texas Southwestern, USA, for visiting us today. It was a great opportunity to learn from an expert. 🇹🇭 🇺🇸#GIPMK

Completed 3 talks at APASL 2025 Beijing and joined meaningful meetings alongside. Sadly, the event was marked by the earthquake in Thailand 😢 — my thoughts are with everyone affected. Now ready to head back home. Wishing safety and strength to all 🇹🇭. #apasl2025

Excited to share that I’ll be speaking at APASL 2025 Beijing #APASL2025

I am honored to visit Hangzhou Xixi Hospital and Zhejiang University. Thank you, Prof. Jin Xiaofai and Prof. Bill Lin, for your kind invitation and hospitality. Look forward to future research collaboration.

RT @DrHuangDQ: Enjoyed speaking on MASLD and alcohol-associated liver disease in Bangkok at the PMK meeting and Grand rounds. Thanks @Sakka….

RT @scottisaacsmd: Diabetes medications in #MASLD and #MASH.

Why do we need more real-world evidence in HCC treatment? .#LiverCancerSummit .@EASLnews

Multidisciplinary team (MDT) involvement in liver cancer treatment is beneficial, but it can sometimes introduce bias. #LiverCancerSummit .@EASLnews

Great news‼️Our MASLD team has 9⃣ abstract submissions accepted for #DDW2025! Excited to present 3 as Lecture Presentations. Grateful to work with such an incredible team! See you in San Diego!⭐. #GIPMK.#DDW2025.@DDWMeeting

AUD is highly prevalent after bariatric surgery, with rising cases of ARLD in this population. Patients with ARLD post-bariatric surgery have poorer outcomes. #SLDSummit .@EASLnews

RT @PetrosVon: @DrNadolsky Ooops a new (another) study that shows it's maybe beyond only calories.